FlexWave Trial: Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb Spasticity

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Stroke, Spasticity, Muscle

In brief

Extracorporeal shock wave therapy (ESWT) has emerged as an effective therapeutic intervention for addressing post-stroke limb spasticity. This research aims to explore the therapeutic implications of focused ESWT for wrist and finger flexor muscles in patients suffering from post-stroke upper limb spasticity.

Key facts

Study ID: NCT06365476
Run by: National Taiwan University Hospital
People needed: 40
Starts: 2024-04-15
Expected to finish: 2027-04-15
Last updated by the study team: 2025-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Individuals aged 18 years or older with unilateral cerebral stroke.
Wrist and finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale.
Stable medical condition and vital signs.
Conscious and able to comply with instructions.

You may not qualify if…

History of more than one stroke, traumatic brain injury, or cerebral neoplasm.
Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal diseases affecting muscle tone assessment.
Contraindications for shockwave intervention, such as malignancies, coagulopathies, local infections, or use of cardiac pacemakers.
Undergone shockwave therapy or botulinum toxin injections for post-stroke spasticity in the past three months.
Cognitive, consciousness, or language impairments preventing participation in the intervention or functional assessments.

Where it is running

Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital — Taipei, Taipei, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.